Z-0188-2013 Class III Terminated
FDA device recall Z-0188-2013 was initiated by Roche Molecular Systems, Inc. on Jul 31, 2012 and is designated Class III. Reason for recall: It was identified that BRAF controls dispositioned as "Internal Use Only" were incorrectly packaged into cobas 4800 BRAF V600 Mutation Test CE-IVD kit lot R03607 and released for distribution. Two… The recall status is terminated (terminated Sep 11, 2013). Affected quantity: 44 kits.
Recall details
- Product Type
- Devices
- Report Date
- Nov 7, 2012
- Initiation Date
- Jul 31, 2012
- Termination Date
- Sep 11, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 44 kits
Product description
cobas 4800 BRAF V600 Mutation Test for In Vitro Diagnostic Use Roche Molecular Systems, Inc., Product Usage: The primary use of the cobas 4800 BRAF V600 Mutation Test is the detection of the BRAF V600 mutations in DNA extracted from formalin-fixed, paraffin-embedded human melanoma tissue. It is intended to be used as an aid in selecting melanoma patients whose tumors carry BRAF V600 mutations for treatment with Zelboraf (vemurafenib).
Reason for recall
It was identified that BRAF controls dispositioned as "Internal Use Only" were incorrectly packaged into cobas 4800 BRAF V600 Mutation Test CE-IVD kit lot R03607 and released for distribution. Two control batches manufactured during two process validation studies are involved: PV7711: BRAF Mutant (MUT) Control PV0853: BRAF Wild Type (WT) Control
Distribution pattern
Worldwide Distribution - Australia, Austria, Belgium, China, Hungary, Turkey and United Kingdom.
Code information
Material number 05985595190; Lot number R03607
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0188-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026